At Johns Hopkins, the new Precision Rehabilitation Center of Excellence will develop personalized diagnostics and interventions.
Pediatric and adult cancer patients in the District of Columbia and elsewhere will now have access to one of the most advanced, lifesaving proton technologies offered in the U.S.
Big data helps clinicians provide tailored treatment.
Johns Hopkins researchers say they found biomarkers of Alzheimer’s disease in spinal fluid samples of older patients hospitalized to repair hip fractures.
Johns Hopkins researchers report they unexpectedly found the same genetic change–one in a gene involved in muscle formation–in five of the tumors.
A Johns Hopkins “drug librarian” developed a new compound as a potential treatment for a common surgery complication
Experts at Johns Hopkins call for a redefinition of precision medicine to ensure its success, and propose a new approach.
Genetic tests for patients with precursor lesions might reveal those at greatest risk.
Female adolescent blood donors are more likely to have low iron stores and iron deficiency anemia than adult female blood donors and nondonors.
Johns Hopkins researchers used PET scans and a rabbit model to show how too little of TB drug reaches brain TB lesions
Experts say additional reference genomes from different populations are needed for research.
An algorithm developed by researchers at Johns Hopkins makes it easier and faster to spot similarities in how patients’ bodies respond to autoimmune diseases.
Johns Hopkins Medicine and the Johns Hopkins University Applied Physics Laboratory (APL) have joined in an effort to revolutionize the diagnosis and treatment of disease by using rigorous data analysis and systems engineering practices.